Drug Profile
Research programme: G protein-coupled receptor modulators - Cara Therapeutics
Alternative Names: GPCR modulators - Cara TherapeuticsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Cara Therapeutics
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in USA
- 26 Feb 2007 Preclinical trials in Inflammation in USA (unspecified route)